Newcastle’s NIHR Medtech and In vitro diagnostics Co-operative site announced
The NIHR MICs, launched on 1 January 2018, have the remit of building expertise and capacity in the NHS to develop new medical technologies.
The NIHR Medtech and In vitro diagnostic Co-operatives (MICs) replace the NIHR Healthcare Technology Co-operatives (HTCs) and NIHR Diagnostic Evidence Co-operatives (DECs), incorporating and retaining the remits of both.
They will provide evidence on commercially-supplied in vitro diagnostic (IVD) tests. Leading NHS organisations act as centres of expertise, bringing together patients, clinicians, researchers, commissioners and industry. More than £14 million over 5 years has been awarded across 11 NIHR MICs, of which Newcastle is one, receiving £1.25m over five years.
The Newcastle Molecular Pathology Node will be collaborating with the MIC on a variety of projects, please watch this space for further updates.